Waverly Internal Medicine Featured in Columbia Maryland Business List
Press Release | www.prlog.org | 7 hours 54 minutes ago
Waverly Internal Medicine Featured in Columbia Maryland Business List. Howard County medical office Waverly Internal Medicine featured on ColumbiaMarylandbusinesslist.com
Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery
Press Release | www.prweb.com | 11 hours 23 minutes ago
PR: Sinusitis patients life is regularly impacted by acute sinusitis or chronic sinusitis, Sinus Dynamics non-invasive nasal sinus treatment with Nasal nebulizer offers the convenience of treating all types of Sinusitis without any limitation or interference associated with any sinus surgery.
George's Marvellous Medicine
Press Release | www.bmj.com | 12 hours 50 minutes ago
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
http://www.bmj.com/cgi/content/short/339/nov24_2/b4971?rss=1
Delcath Systems, Inc. Sponsors Satellite Session at World Meeting of Melanoma/Skin Cancer Centers (PR Newswire)
Press Release | finance.yahoo.com | 13 hours 15 minutes ago
NEW YORK, Nov. 24 /PRNewswire-FirstCall/ -- Delcath Systems, Inc., (Nasdaq: DCTH - News) a medical technology company testing its proprietary treatment method for primary and metastatic
http://finance.yahoo.com/news/Delcath-Systems-Inc-Sponsors-prnews-1877012127.html?x=0&.v=1
Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
Press Release | www.pharmiweb.com | 23 hours 45 minutes ago
Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease- Committee for Medicinal Products for Human Use (CHMP) Grants Accelerated AssessmentPR NewswireDUBLIN, November 24DUBL
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=11305
Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter
Press Release | www.prnewswire.com | Nov 23, 2009
Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter.
Infectious Disease Experts Call for 10 New Antibiotics by 2020
Press Release | www.infectioncontroltoday.com | Nov 23, 2009
The Infectious Diseases Society of America (IDSA) has asked for a commitment from the Obama administration and the European Union to further the Society s mission to achieve the development of 10 new antibiotics within the next 10 years, known as the 10 x 20 Initiative. The World Health
Medical News: Mammography Guidelines Intensify Healthcare Reform Debate - in Public Health &
Press Release | www.medpagetoday.com | Nov 23, 2009
WASHINGTON -- The emotional debate over a federal panel's proposal to end routine mammograms for women in their 40s has reignited controversy over a contentious healthcare reform issue: comparative ef
http://www.medpagetoday.com/PublicHealthPolicy/Washington-Watch/17151
The M&A Trend Continues: An Analysis of the Key Mergers and Acquisitions of 2009
Press Release | www.frost.com | Nov 23, 2009
The biggest mergers and acquisitions witnessed so far in 2009 have been the Pfizer-Wyeth acquisition for $68 billion, Roche-Genentech $46.8 billion, Merck-Schering Plough $41B and Gilead Sciences-CV Therapeutics $1.4B. This accounted for a total of $157 billion dollars.
http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=185479087
Sweet! Sugared Polymer a New Weapon Against Allergies and Asthma-11/19/09
Press Release | www.hopkinsmedicine.org | Nov 21, 2009
Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Their advance is a significant step toward crafting pharmaceuticals to fight these often life-endangering
http://www.hopkinsmedicine.org/Press_releases/2009/11_19_09.html
